Dermatomyositis is an uncommon disease marked by muscle weakness and a particular rash. The condition can affect adults and youngsters. In adults, dermatomyositis usually occurs from the late 40s to early 60s. In children, it most frequently appears between 5 and 15 years aged. Treatment includes medication or other therapies. In rare cases, surgery could also be wont to remove calcium deposits.

this continuing medical education series reviews the initial evaluation of patients with suspected dermatomyositis (DM), the relevant work-up for malignancy and interstitial lung disease once a diagnosis of DM is made, and treatment recommendations for patients with DM based on disease severity, the presence of systemic symptoms, and myositis-specific antibody (MSA) profiles. This review emphasizes the emerging role of MSAs in the diagnosis of DM and highlights how MSAs can be used to guide the appropriate work-up for malignancy and interstitial lung disease. The treatment approach proposed by this continuing medical education series discusses both established and novel therapies for DM and highlights the importance of considering lesion type, degree of muscle involvement